Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism

被引:20
|
作者
Ogata, Hiroko [1 ]
Yamazaki, Yuto [1 ]
Tezuka, Yuta [2 ,3 ,5 ]
Gao, Xin [1 ]
Omata, Kei [2 ,3 ]
Ono, Yoshikiyo [2 ,3 ]
Kawasaki, Yoshihide [4 ]
Tanaka, Tomoaki [6 ]
Nagano, Hidekazu [6 ]
Wada, Norio [7 ]
Oki, Yutaka [8 ]
Ikeya, Akira [8 ]
Oki, Kenji [9 ]
Takeda, Yoshiyu [10 ]
Kometani, Mitsuhiro [10 ]
Kageyama, Kazunori [11 ]
Terui, Ken [11 ]
Gomez-Sanchez, Celso E. [12 ,13 ]
Liu, Shujun [14 ]
Morimoto, Ryo [3 ]
Joh, Kensuke [15 ]
Sato, Hiroshi [16 ,17 ]
Miyazaki, Mariko [3 ]
Ito, Akihiro [4 ]
Arai, Yoichi [4 ]
Nakamura, Yasuhiro [18 ]
Ito, Sadayoshi [3 ]
Satoh, Fumitoshi [2 ,3 ]
Sasano, Hironobu [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi, Japan
[2] Tohoku Univ, Grad Sch Med, Div Clin Hypertens Endocrinol & Metab, Sendai, Miyagi, Japan
[3] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan
[4] Tohoku Univ Hosp, Div Urol, Sendai, Miyagi, Japan
[5] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[6] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan
[7] Sapporo City Gen Hosp, Dept Diabet & Endocrinol, Sapporo, Hokkaido, Japan
[8] Hamamatsu Univ Sch Med, Dept Endocrinol & Metab, Shizuoka, Japan
[9] Hiroshima Univ Hosp, Grad Sch Biochem & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan
[10] Kanazawa Univ, Grad Sch Med, Dept Cardiovasc & Internal Med, Kanazawa, Ishikawa, Japan
[11] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori, Japan
[12] Univ Mississippi, Dept Med, Div Endocrinol, Med Ctr, Jackson, MS, Brazil
[13] GV Sonny Montgomery VA Med Ctr, Res & Med Serv, Jackson, MS, Brazil
[14] Second Hosp Jilin Univ, Dept Nephrol, Changchun, Peoples R China
[15] Jikei Univ, Dept Pathol, Sch Med, Tokyo, Japan
[16] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan
[17] Fac Pharmaceut Sci, Sendai, Miyagi, Japan
[18] Tohoku Med & Pharmaceut Univ, Fac Med, Div Pathol, Sendai, Miyagi, Japan
基金
日本学术振兴会;
关键词
11H beta SD; aldosterone; histopathology; hypertension; mineralocorticoid receptor; renin; GLOMERULAR-FILTRATION-RATE; MINERALOCORTICOID RECEPTOR; RISK-FACTORS; KIDNEY; PREVALENCE; NEPHROPATHY; ICAM-1;
D O I
10.1161/HYPERTENSIONAHA.121.17436
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The rapid progression of chronic kidney disease and higher incidence of cardiovascular complications are well known in patients with hyperaldosteronism. However, detailed renal histopathologic characteristics of this disease have remained unknown. Therefore, renal biopsy specimens of 19 cases with unilateral hyperaldosteronism were compared with 22 autopsy renal cases of estimated glomerular filtration rate-matched essential hypertension without nephropathy or endocrine disorders to explore the hyperaldosteronism-specific histopathologic renal changes in this study. Global and segmental glomerulosclerosis, interstitial fibrosis, infiltration of inflammatory cells, arteriosclerosis, hyalinization of arterioles and immunoreactivity of mineralocorticoid receptor, 11 beta-hydroxysteroid dehydrogenase type 1 and 2, and renin were all quantitatively evaluated. The ultrastructural analysis was added in 3 hyperaldosteronism cases. Both mineralocorticoid receptor (P<0.01) and 11 beta-hydroxysteroid dehydrogenase type 2 (P<0.01) were significantly higher in renal tubules of hyperaldosteronism, which could result in enhancement of in situ aldosterone effects in hyperaldosteronism kidneys. Interstitial fibrosis was significantly more marked in hyperaldosteronism (P<0.01). The proportion of segmental glomerulosclerosis was also significantly higher in hyperaldosteronism (P<0.01). There were no significant differences of global glomerulosclerosis between 2 groups (P=0.08). Glomerular size was significantly larger in hyperaldosteronism (P<0.01). In medium size artery, luminal stenosis tended to be more marked (P=0.08), and intima-to-media ratio was significantly lower (P=0.02) in hyperaldosteronism. Arteriolar hyalinization was significantly more pronounced (P<0.01), especially at efferent arterioles (P<0.01) in hyperaldosteronism. Results above demonstrated more pronounced whole renal damages in hyperaldosteronism. Results of our present study also indicated the potential clinical significance of early intervention using mineralocorticoid receptorantagonistsor blockers.
引用
收藏
页码:411 / 421
页数:11
相关论文
共 50 条
  • [31] Factors associated with renal function change after unilateral adrenalectomy in patients with primary aldosteronism
    Lu, Yu-Cheng
    Liu, Kao-Lang
    Wu, Vin-Cent
    Wang, Shuo-Meng
    Lin, Yen-Hung
    Chueh, Shih-Chieh Jeff
    Wu, Kwan-Dun
    Huang, Kuo-How
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 831 - 837
  • [32] Comprehensive Analysis of Steroid Biomarkers for Guiding Primary Aldosteronism Subtyping
    Turcu, Adina F.
    Wannachalee, Taweesak
    Tsodikov, Alexander
    Nanba, Aya T.
    Ren, Jianwei
    Shields, James J.
    O'Day, Patrick J.
    Giacherio, Donald
    Rainey, William E.
    Auchus, Richard J.
    HYPERTENSION, 2020, 75 (01) : 183 - 192
  • [33] Risk of ischemic stroke in primary aldosteronism patients
    Kao, Chih-Chin
    Wu, Che-Hsiung
    Lin, Yen-Hung
    Chang, Chin-Chen
    Chen, Hsi-Hsien
    Wu, Mai-Szu
    Wu, Vin-Cent
    Wu, Kwan-Dun
    CLINICA CHIMICA ACTA, 2015, 438 : 86 - 89
  • [34] Clinical characteristics of primary aldosteronism screened from Chinese patients with hypertension: The China primary aldosteronism prospective study
    Hu, Zhe
    Chen, Xin
    Cheng, Yi-Bang
    Zhong, Ping
    Li, Qing-An
    Zhao, Yu
    Luan, Hong
    Ren, Jie
    Chen, Gai-Ling
    Wang, Ji-Guang
    JOURNAL OF CLINICAL HYPERTENSION, 2024, 26 (09) : 1082 - 1089
  • [35] Impact of primary aldosteronism on renal function in patients with type 2 diabetes
    Katsuragawa, Sho
    Tsurutani, Yuya
    Takiguchi, Tomoko
    Saito, Jun
    Nishikawa, Tetsuo
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (02) : 217 - 225
  • [36] Clinical implications of renal cyst in primary aldosteronism
    Ogasawara, M
    Nomura, K
    Toraya, S
    Kikuchi, C
    Katayama, M
    Ujihara, M
    Kono, A
    Demura, H
    ENDOCRINE JOURNAL, 1996, 43 (03) : 261 - 268
  • [37] Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism
    Rossi, Gian Paolo
    Crimi, Filippo
    Rossitto, Giacomo
    Amar, Laurence
    Azizi, Michel
    Riester, Anna
    Reincke, Martin
    Degenhart, Christoph
    Widimsky, Jiri
    Naruse, Mitsuhide
    Deinum, Jaap
    Kool, Leo Schultze
    Kocjan, Tomaz
    Negro, Aurelio
    Rossi, Ermanno
    Kline, Gregory
    Tanabe, Akiyo
    Satoh, Fumitoshi
    Rump, Lars Christian
    Vonend, Oliver
    Willenberg, Holger S.
    Fuller, Peter J.
    Yang, Jun
    Chee, Nicholas Yong Nian
    Magill, Steven B.
    Shafigullina, Zulfiya
    Quinkler, Marcus
    Oliveras, Anna
    Wu, Vin Cent
    Kratka, Zuzana
    Barbiero, Giulio
    Battistel, Michele
    Seccia, Teresa Maria
    HYPERTENSION, 2022, 79 (01) : 187 - 195
  • [38] Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism
    Engler, Lukas
    Adolf, Christian
    Heinrich, Daniel A.
    Brem, Anna-Katharine
    Riester, Anna
    Franke, Anna
    Beuschlein, Felix
    Reincke, Martin
    Steiger, Axel
    Kuenzel, Heike
    ENDOCRINE CONNECTIONS, 2019, 8 (04): : 407 - 415
  • [39] Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism A Tissue Doppler Study
    Cesari, Maurizio
    Letizia, Claudio
    Angeli, Paolo
    Sciomer, Susanna
    Rosi, Silvia
    Rossi, Gian Paolo
    CIRCULATION-CARDIOVASCULAR IMAGING, 2016, 9 (06)
  • [40] Autonomous Cortisol Secretion Influences Psychopathological Symptoms in Patients With Primary Aldosteronism
    Gendreitzig, Pauline
    Kuenzel, Heike E.
    Adolf, Christian
    Handgriff, Laura
    Mueller, Lisa
    Holler, Finn
    Sturm, Lisa
    Heinrich, Daniel A.
    Reincke, Martin
    Quinkler, Marcus
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (06) : E2423 - E2433